Generic drug purveyor Akorn (AKRX +0.00%) has expanded its portfolio of ophthalmic products thanks to a deal with Merck (MRK 1.72%). The company announced it has acquired the U.S. rights to a trio of ...
COSOPT PF (dorzolamide HCl, timolol maleate) 2%, 0.5% ophthalmic solution by Merck Cosopt PF (dorzolamide HCl 2%, timolol maleate 0.5% ophthalmic solution), the preservative-free formulation of Cosopt ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it signed an agreement for Santen Pharmaceutical Co., Ltd. (Santen) ...
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced that it has acquired from Merck (NYSE: MRK), the U.S. rights to three branded ...
A nationwide shortage of a special kind of eye drop to treat glaucoma has hit close to home for one Franklin teenager. On January 24, the Food and Drug Administration placed Dorzolamide Hydrochloride ...
Dorzolamide HCl 2%, timolol maleate 0.5%; oph soln; preservative-free. Mild-to-moderate COPD or bronchospastic disease, or severe renal impairment: not recommended. Hepatic impairment. Surgery. May ...
Please provide your email address to receive an email when new articles are posted on . Santen Pharmaceutical and Merck have entered into an agreement by which Santen will purchase Merck’s ...
Akorn, a leading specialty pharmaceutical company, has completed its previously announced sale of seven branded ophthalmic products to Théa Pharma. Under the deal, Théa Pharma acquired seven products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results